Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

TNXP

Tonix Pharmaceuticals (TNXP)

Tonix Pharmaceuticals Holding Corporation
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:TNXP
일자시간출처헤드라인심볼기업
2024/04/0205:15GlobeNewswire Inc.Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Operational HighlightsNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/03/2822:32GlobeNewswire Inc.Tonix Pharmaceuticals Announces Pricing of $4.4 Million Registered Direct OfferingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/03/2521:00GlobeNewswire Inc.Tonix Pharmaceuticals Receives Rare Pediatric Disease Designation from the FDA for TNX-2900 for the Treatment of Prader-Willi SyndromeNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/03/2121:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Poster Presentation Describing Discovery of Novel Next-Generation Oxytocin Analogues at the American Chemistry Society (ACS) Spring 2024 MeetingNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/03/2021:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya™ for the Management of FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/03/1921:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Transition to Fully Integrated Biopharmaceutical Company Expected on April 1, 2024NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/03/1221:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Presentation at BIO-Europe SpringNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/03/1121:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/03/1121:00GlobeNewswire Inc.Tonix Pharmaceuticals Reports Improvement in “Brain Fog,” in Fibromyalgia Patients Treated with Tonmya™ in RESILIENT, an NDA-Enabling Phase 3 Clinical Trial, at the 6th International Congress on Controversies in FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/03/0723:37GlobeNewswire Inc.New to The Street Announces TV Episode 560 with its Five Business Guest Interviews, Airs as Sponsored Programming on Bloomberg TV Tonight, Thursday, March 7, 2024, at 9:30 PM PTNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/03/0722:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/03/0722:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Publication in Psychiatry Research Showing Activity of Bedtime TNX-102 SL on PTSD Symptoms and Sleep Quality in Military-Related PTSD at Four Weeks of TherapyNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/03/0707:01Edgar (US Regulatory)Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]NASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/03/0622:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/03/0622:00GlobeNewswire Inc.Tonix Pharmaceuticals Selects EVERSANA® to Support Launch Strategy and Commercialization Planning of Tonmya™ for the Management of FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/03/0522:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/03/0522:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Translation of Preclinical Pharmacokinetic Parameters of TNX-1500 (Fc-modified humanized anti-CD40L mAb) Supports Monthly i.v. Dosing in HumansNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/03/0107:08Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/03/0107:07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/03/0107:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/03/0107:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/02/2922:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Presentation at The 6th International Congress on Controversies in FibromyalgiaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/02/2822:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/02/2822:00GlobeNewswire Inc.Tonix Pharmaceuticals Completes Clinical Stage of Phase 1 Trial for TNX-1500 (Fc-modified humanized anti-CD40L mAb) in Healthy VolunteersNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/02/2722:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/02/2722:00GlobeNewswire Inc.Tonix Pharmaceuticals Announces Positive Results from Clinical Pharmacokinetic Bridging Study of Tonmya™ to Support Development and Partnering in Japan and ChinaNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/02/2323:30GlobeNewswire Inc.New to The Street Announces Line-up of its Corporate Interviews Airing on its Leadership and Business Televised SeriesNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/02/2022:00GlobeNewswire Inc.Tonix Pharmaceuticals to Participate in the 2024 BIO CEO & Investor ConferenceNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/02/1623:30GlobeNewswire Inc.New to The Street Airs Episode 556 Featuring Five Corporate Interviews, Broadcast on the FOX Business Network Monday, February 19, 2024, at 10:30 PM PTNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
2024/02/1607:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:TNXPTonix Pharmaceuticals Holding Corporation
 검색 관련기사 보기:NASDAQ:TNXP